Also, FDA is proposing two other limitations within the submission of the supplemental PMTA. Below proposed § 1114.15(a), a supplemental PMTA couldn't be submitted where by the advertising and marketing purchase for the initial tobacco product is withdrawn or has long been briefly suspended or is the topic of non permanent suspension or withdraw